Cell transplantation: A future therapy for narcolepsy?

CNS and Neurological Disorders - Drug Targets

Volumn 8, Issue 4, 2009, Pages 309-314

  Arias Carrión, Oscar ^a   Murillo Rodríguez, Eric ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Universidad del Mayab   (Mexico)

Author keywords

Animal models; Cell transplant; Hypocretin orexin neurons; Lateral hypothalamus; Narcolepsy; Sleep

Indexed keywords

OREXIN; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS; OREXINS; PROTEIN SYNTHESIS INHIBITOR; RIBOSOME INACTIVATING PROTEIN 1; SAPORIN; SIGNAL PEPTIDE;

CELL TRANSPLANTATION; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; HUMAN; HYPOTHALAMUS; NARCOLEPSY; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; REM SLEEP DEPRIVATION; REVIEW; ANIMAL; BIOLOGICAL MODEL; BRAIN TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; GENETICS; LATERAL HYPOTHALAMUS; METABOLISM; METHODOLOGY; NERVE CELL; PONS; TRANSPLANTATION;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, NEUROLOGICAL; NARCOLEPSY; NEURONS; NEUROPEPTIDES; PONS; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RIBOSOME INACTIVATING PROTEINS, TYPE 1;

EID: 70350450401     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152709788921681     Document Type: Review

References (42)

1. Sakurai, T.; Amemiya, A.; Ishii, M.; Matsuzaki, I.; Chemelli, R. M.; Tanaka, H.; Williams, S. C.; Richardson, J. A.; Kozlowski, G. P.; Wilson, S.; Arch, J. R.; Buckingham, R. E.; Haynes, A. C.; Carr, S. A.; Annan, R. S.; McNulty, D. E.; Liu, W. S.; Terrett, J. A.; Elshourbagy, N. A.; Bergsma, D. J.; Yanagisawa, M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 1998, 92, 573-585.
2. de Lecea, L.; Kilduff, T. S.; Peyron, C.; Gao, X.; Foye, P. E.; Danielson, P. E.; Fukuhara, C.; Battenberg, E. L.; Gautvik, V. T.; Bartlett, F. S., 2nd; Frankel, W. N.; van den Pol, A. N.; Bloom, F. E.; Gautvik, K. M.; Sutcliffe, J. G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA, 1998, 95, 322-327.
3. Peyron, C.; Tighe, D.K.; Van den Pol, A.N.; De Lecea, L.; Heller, H.C.; Sutcliffe, J.G.; Kilduff, T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci., 1998, 18, 9996-10015.
4. Sakurai, T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci., 2007, 8, 171-181.
5. Hagan, J.J.; Leslie, R.A.; Patel, S.; Evans, M.L.; Wattam, T.A.; Holmes, S.; Benham, C.D.; Taylor, S.G.; Routledge, C.; Hemmati, P.; Munton, R.P.; Ashmeade, T.E.; Shah, A.S.; Hatcher, J.P.; Hatcher, P.D.; Jones, D.N.; Smith, M.I.; Piper, D.C.; Hunter, A.J.; Porter, R.A.; Upton, N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA, 1999, 96, 10911-10916.
6. Brown, R.E.; Sergeeva, O.A.; Eriksson, K.S,; Haas, H.L. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci., 2002, 22, 8850-8859.
7. Bayer, L.; Eggermann, E.; Saint-Mleux, B.; Machard, D.; Jones, B.E.; Muhlethaler, M.; Serafin, M. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J. Neurosci., 2002, 22, 7835-7839.
8. Bayer, L.; Eggermann, E.; Serafin, M.; Saint-Mleux, B.; Machard, D.; Jones, B.; Muhlethaler, M. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur. J. Neurosci., 2001, 14, 1571-1575.
9. Eggermann, E.; Serafin, M.; Bayer, L.; Machard, D.; Saint-Mleux, B.; Jones, B.E.; Muhlethaler, M. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience, 2001, 108, 177-181.
10. Takahashi, K.; Koyama, Y.; Kayama, Y.; Yamamoto, M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin. Neurosci., 2002, 56, 335-336.
11. Siegel, J.M.; Boehmer, L.N. Narcolepsy and the hypocretin system - where motion meets emotion. Nat. Clin. Pract. Neurol., 2006, 2, 548-556.
12. Chemelli, R.M,; Willie, J.T.; Sinton, C.M.; Elmquist, J.K.; Scammell, T.; Lee, C.; Richardson, J.A.; Williams, S.C,: Xiong, Y.; Kisanuki, Y.; Fitch, T.E.; Nakazato, M.; Hammer, R.E; Saper, C.B.; Yanagisawa, M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999, 98, 437-451.
13. Lin, L.; Faraco, J.; Li, R.; Kadotani, H.; Rogers, W.; Lin, X.; Qiu, X.; de Jong, P.J.; Nishino, S.; Mignot, E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 1999, 98, 365-376.
14. Peyron, C.; Faraco, J.; Rogers, W.; Ripley, B.; Overeem, S.; Charnay, Y.; Nevsimalova, S.; Aldrich, M.; Reynolds, D.; Albin, R.; Li, R.; Hungs, M.; Pedrazzoli, M.; Padigaru, M.; Kucherlapati, M.; Fan, J.; Maki, R.; Lammers, G.J.; Bouras, C.; Kucherlapati, R.; Nishino, S.; Mignot, E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med., 2000, 6, 991-997.
15. Thannickal, T. C.; Moore, R. Y.; Nienhuis, R.; Ramanathan, L.; Gulyani, S.; Aldrich, M.; Cornford, M.; Siegel, J. M. Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000, 27, 469-474.
16. Dalal, M.A.; Schuld, A.; Haack, M.; Uhr, M.; Geisler, P.; Eisensehr, I.; Noachtar, S.; Pollmacher, T. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology, 2001, 56, 1749-1751.
17. Kanbayashi, T.; Inoue, Y.; Chiba, S.; Aizawa, R.; Saito, Y.; Tsukamoto, H.; Fujii, Y.; Nishino, S.; Shimizu, T. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J. Sleep Res., 2002, 11, 91-93.
18. Mignot, E.; Lammers, G.J.; Ripley, B.; Okun, M.; Nevsimalova, S.; Overeem, S.; Vankova, J.; Black, J.; Harsch, J.; Bassetti, C.; Schrader, H.; Nishino, S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol., 2002, 59, 1553-1562.
19. Nishino, S.; Ripley, B.; Overeem, S.; Nevsimalova, S.; Lammers, G.J.; Vankova, J.; Okun, M.; Rogers, W.; Brooks, S.; Mignot, E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol., 2001, 50, 381-388.
20. Bourgin, P.; Zeitzer, J.M.; Mignot, E. CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol., 2008, 7, 649-662.
21. Hallmayer. J.; Faraco, J.; Lin, L.; Hesselson, S.; Winkelmann, J.; Kawashima, M.; Mayer, G.; Plazzi, G.; Nevsimalova, S.; Bourgin, P.; Hong, S.S.; Honda, Y.; Honda, M.; Högl, B.; Longstreth, W.T.; Jr.; Montplaisir, J.; Kemlink, D.; Einen, M.; Chen, J.; Musone, S.L.; Akana, M.; Miyagawa, T.; Duan, J.; Desautels, A.; Erhardt, C.; Hesla, P.E.; Poli, F.; Frauscher, B.; Jeong, J.H.; Lee, S.P.; Ton, T.G.; Kvale, M.; Kolesar, L.; Dobrovolná, M.; Nepom, G.T.; Salomon, D.; Wichmann, H.E.; Rouleau, G.A.; Gieger, C.; Levinson, D.F.; Gejman, P.V.; Meitinger, T.; Young, T.; Peppard, P.; Tokunaga, K.; Kwok, P.Y.; Risch N.; Mignot, E. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet., 2009, 6, 708-711.
22. Hara, J.; Beuckmann, C.T.; Nambu, T.; Willie, J.T.; Chemelli, R.M.; Sinton, C.M.; Sugiyama, F.; Yagami, K.; Goto, K.; Yanagisawa, M.; Sakurai, T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron, 2001, 30, 345-354
23. Stirpe, F.; Barbieri, L.; Battelli, M.G.; Soria, M.; Lappi, D.A. Ribosome-inactivating proteins from plants: present status and future prospects. Biotechnology (N Y), 1992, 10, 405-412.
24. Trivedi, P.; Yu, H.; MacNeil, D.J.; Van der Ploeg, L.H.; Guan, X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett., 1998, 438, 71-75.
25. Hervieu, G.J.; Cluderay, J.E.; Harrison, D.C.; Roberts, J.C.; Leslie, R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience, 2001, 103, 777-797.
26. Gerashchenko, D.; Kohls, M.D.; Greco, M.; Waleh, N.S.; Salin-Pascual, R.; Kilduff, T.S.; Lappi, D.A.; Shiromani, P.J. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcolepticlike sleep behavior in the rat. J. Neurosci., 2001, 21, 7273-7283.
27. Gerashchenko, D.; Blanco-Centurion, C.; Greco, M.A.; Shiromani, P.J. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin2-saporin on sleep in Long Evans rats. Neuroscience, 2003, 116, 223-235.
28. Gerashchenko, D.; Murillo-Rodriguez, E.; Lin, L.; Xu, M.; Hallett, L.; Nishino S, Mignot E.; Shiromani, P.J. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp. Neurol., 2003, 184, 1010-1016.
29. Yamamoto, Y.; Ueta, Y.; Hara, Y.; Serino, R.; Nomura, M.; Shibuya, I.; Shirahata, A.; Yamashita, H. Postnatal development of orexin/hypocretin in rats. Mol. Brain Res., 2000, 78, 108-119.
30. Van Den Pol, A.N.; Patrylo, P.R.; Ghosh, P.K.; Gao, X.B. Lateral hypothalamus: early developmental expression and response to hypocretin (orexin). J. Comp. Neurol., 2001, 433, 349-363.
31. Fujiki, N.; Yoshida, Y.; Ripley, B.; Honda, K.; Mignot, E.; Nishino, S. Changes in CSF hypocretin-1 (orexin a) levels in rats across 24 hours and in response to food deprivation. Neuroreport, 2001, 12, 993-997.
32. Yoshida, Y.; Fujiki, N.; Nakajima.; T.; Ripley, B.; Matsumura, H.; Yoneda, H.; Mignot E.; Nishino, S. Fluctuation of extracellular hypocretin-1 (orexin a) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci., 2001, 14, 1075-1081.
33. Desarnaud, F.; Murillo-Rodriguez, E.; Lin, L.; Xu, M.; Gerashchenko, D.; Shiromani, SN.; Nishino, S.; Mignot, E.; Shiromani, P.J. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep, 2004, 27, 851-856.
34. Zeitzer, J.M.; Nishino, S.; Mignot, E. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions. Trends Pharmacol. Sci., 2006, 27, 368-374.
35. Siegel, J.M.; Boehmer, L.N. Narcolepsy and the hypocretin system - where motion meets emotion. Nat. Clin. Pract. Neurol., 2006, 2, 548-556.
36. Longstreth, W.T.; Jr.; Koepsell, T.D.; Ton, T.G.; Hendrickson, A.F.; van Belle, G. The epidemiology of narcolepsy. Sleep, 2007, 30, 13-26.
37. Deierborg, T.; Soulet, D.; Roybon, L.; Hall, V.; Brundin, P. Emerging restorative treatments for Parkinson's disease. Prog. Neurobiol., 2008; 85, 407-432.
38. Lindvall, O.; Lokaia, Z.; Martinez-Serrano, A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med., 2004, 10, S42-S50.
39. Liu, M.; Thankachan, S.; Kaur, S.; Begum, S.; Blanco-Centurion, C.; Sakurai, T.; Yanagisawa, M.; Neve, R.; Shiromani, P.J. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur. J. Neurosci., 2008; 28, 1382-1393.
40. Drucker-Colín, R.; Verdugo-Díaz, L. Cell transplantation for Parkinson's disease: present status. Cell Mol. Neurobiol., 2004, 24, 301-316.
41. Arias-Carrión, O., Murillo-Rodriguez, E., Xu, M., Blanco-Centurion, C., Drucker-Colín, R., Shiromani, P.J., Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results. Sleep, 2004, 27, 1465-1470.
42. Arias-Carrión, O.; Drucker-Colín, R.; Murillo- Rodríguez, E., Survival rates through time of hypocretin grafted neurons within their projection site. Neurosci. Lett., 2006, 404, 93-97.